Table 1.
Syndromic forms of autism that have been investigated in iPSC-derived studies.
Disease | Gene | Location | Function | Symptoms | References |
---|---|---|---|---|---|
Fragile X Syndrome | FMR1 (CGG expansion in the 5'UTR sequence) | Xq27.3 | RNA-binding molecule/ Regulates local translation | Intellectual Disability, Developmental Delay, Social Impairment, Hyperactivity Machroorchidism | (9) |
Rett Syndrome | MECP2 | Xq28 | Methyl CpG DNA binding molecule/Regulates gene transcription | Affects essentially Females (X-linked forms) Intellectual Disability, Stereotyped Behavior, Epilepsy, Regression during childhood |
(10) |
CDKL5 | Xp22.13 | Serine/Threonine Kinase | (12) | ||
NTNG1 | 1p13.3 | Presynaptic Ligand involved in Axonal projection | (13) | ||
MEF2C | 5q14.3 | MADS box transcription enhancer factor 2; DNA binding molecule | (14) | ||
Tuberous Sclerosis | TSC1 | 9q34.13 | Interact with the tuberin to negatively regulate the mTOR pathway | Multisystemic disease involving the brain (Learning Deficits, Intellectual Disability, Epilepsy, Structural Brain abnormalities), skin (e.g., hypomelanotic macules, shagreen patches, angiofibromas), eyes (e.g., angiofibromas), Kidneys, heart e.g., rhabdomyomas) and lungs (lymphangioleiomyomatosis) | (11, 15) |
TSC2 | 16p13.3 | GTPAse activating protein/interact with the tuberin to regulate the mTOR pathway | |||
Phelan-McDermid Syndrome | SHANK3 | 22q13.33 | Scaffold protein of the post-synaptic compartment. Involved in synapse formation and in dendritic spine maturation | Global Developmental delay, Hypotonia, Absence of Speech or Speech delay, Dysmorphic Features | (16) |
FoxG1 Deletion Syndrome | FOXG1 | 14q12 | Forked-head transcription factor; Involved in brain development | Microcephaly, partial or complete agenesis of the corpus callosum, Intellectual Disability, Epilepsy, Autistic Features | (17) |